Search Within

Roni Shouval

Formats
  1. Meeting Abstract (88)
  2. Journal Article (58)
  3. Review (6)
  4. Research Letter (4)
  5. Editorial (3)
  6. Correspondence (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (163)
  2. Center for Hematologic Malignancies (106)
  3. Department of Medicine (106)
  4. Bone Marrow Transplant (99)
  5. CTCR Scholars (83)
  6. Survivorship Research (80)

More Groups

People
  1. Miguel-Angel Perales (95)
  2. Michael Scordo (78)
  3. Gunjan Shah (75)
  4. Maria Palomba (70)
  5. Parastoo Dahi (62)
  6. Sean Devlin (62)

More People

Years
  1. 2025 (16)
  2. 2024 (38)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (60)
  2. Bone Marrow Transplantation (20)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (11)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (75)
  2. Nature Publishing Group (26)
  3. Elsevier Inc. (25)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (163)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: An ALWP EBMT study
    Journal Article

    Fein, J. A.; Shouval, R.; Galimard, J. E.; Labopin, M.; Socié, G.; Finke, J.; Cornelissen, J. J.; Malladi, R.; Itälä-Remes, M.; Chevallier, P.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
    Meeting Abstract

    Cederquist, G.; Hubbeling, H.; Tringale, K.; Shah, G.; Alarcon Tomas, A.; Shouval, R.; Hajj, C.; Fregonese, B.; Lee, J.; Dahi, P. B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profile in patients receiving CAR T‐cell therapy for aggressive B‐cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J.; Devlin, S. M.; Shah, G. L.; Scordo, M.; Dahi, P. B.; Lin, R. J.; Imber, B.; Parascondola, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Point‐of‐care anti‐BCMA CAR T‐cell therapy induces encouraging response rates in high‐risk relapsed/refractory multiple myeloma
    Meeting Abstract

    Magen, H.; Fried, S.; Itzhaki, O.; Shem‐Tov, N.; Danylesko, I.; Yerushalmi, R.; Marcus, R.; Shouval, R.; Nevo, L.; Shapira‐Frommer, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients
    Journal Article

    Nguyen, C. L.; Markey, K. A.; Miltiadous, O.; Dai, A.; Waters, N.; Sadeghi, K.; Fei, T.; Shouval, R.; Taylor, B. P.; Liao, C.; more...
    Cell (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Prediction of nonrelapse mortality in patients with acute myeloid leukemia and acute lymphoblastic leukemia receiving allogeneic stem cell transplantation with posttransplantation cyclophosphamide-based graft versus host disease prophylaxis
    Journal Article

    Hermans, S. J. F.; Versluis, J.; Labopin, M.; Giebel, S.; van Norden, Y.; Moiseev, I.; Blaise, D.; Díez Martín, J. L.; Meijer, E.; Rovira, M.; more...
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation after chimeric antigen receptor T cell therapy in large B cell lymphoma
    Journal Article

    Fried, S.; Shouval, R.; Walji, M.; Flynn, J. R.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Tomas, A. A.; Fein, J. A.; Devlin, S. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save